From April 1, 2022 to June 30, 2022, the company has repurchased 1,417,400 shares, representing 0.16% for CNY 119.37 million. With this, the company has completed the repurchase of 3,909,800 shares, representing 0.45% for CNY 369.39 million under the buyback announced on February 13, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
52.25 CNY | +2.63% | +3.90% | -4.95% |
07:55am | Tigermed Consulting's Profit, Revenue Climb in 2023 | MT |
Mar. 28 | Hangzhou Tigermed Consulting Co., Ltd Announces Final Dividend for the Year Ended December 31, 2023, Payable on 31 July 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.95% | 5.83B | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |
- Stock
- Equities
- Stock Hangzhou Tigermed Consulting Co., Ltd - Shenzhen S.E.
- News Hangzhou Tigermed Consulting Co., Ltd
- Tranche Update on Hangzhou Tigermed Consulting Co., Ltd's Equity Buyback Plan announced on February 13, 2022.